Both share the GLP-1 class side-effect profile, led by gastrointestinal symptoms: nausea, vomiting, diarrhea, and constipation, worst during dose increases
0.25mg dose: Draw to 7.5 units (round to 7 or 8) 0.5mg dose: Draw to 15 units 1.0mg dose: Draw to 30 units 1.7mg dose: Draw to 51 units 2.0mg dose: Draw to 60 units 2.4mg dose: Draw to 72 units These unit measurements are easier to read on a standard insulin syringe, which is why the 3mL reconstitution has become the default recommendation across most research communities
When metabolic rate increases, the body burns more calories and weight regain becomes less likely
Changes in regional body composition over 8 years in a randomized lifestyle trial: the look AHEAD study
Evaluating semaglutide and tirzepatide in early non-responders While semaglutide produces 15-17% mean weight loss and tirzepatide yields even more impressive 16-22.5% reductions, neither has been thoroughly evaluated in early non-responders